OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Immunology Research is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Abstract P039: The immune profile of colorectal and pancreas adenocarcinomas: Differences between central and peripheric tumor regions	173
Abstract P003: Efficacy results of a novel vaccine composed of stimulated and haptenized tumors cells in Balbc mice grafted with murine colon adenocarcinoma CT26 cells	112
A Sampling of Highlights from the Literature	110
A Sampling of Highlights from the Literature	102
Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy	96
Exercise as an Immune Boost: Mechanism-Driven Support for Lifestyle Interventions	94
Optimal Neoantigen Cancer Vaccines Target CD8+ and CD4+ T Cells with Multiple Antigens	79
Reciprocal Interactions Between the Gut Microbiome and Mammary Tissue Mast Cells Promote Metastatic Dissemination of HR+ Breast Tumors	73
Transforming the Dark into Light: A Siglec-9 Switch	68
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer	66
IL18 at the Crossroads between Chronic Inflammation and T-cell Exhaustion in Pancreatic Cancer	66
IL-15 complex enhances agonistic anti-CD40 + anti-PDL1 by correcting the T-bet to Tox ratio in CD8+ T cells infiltrating pancreatic ductal adenocarcinoma	64
A Population of TIM4+FOLR2+ Macrophages Localized in Tertiary Lymphoid Structures Correlates to an Active Immune Infiltrate Across Several Cancer Types	59
The ω-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid Enhances NK-Cell Antitumor Effector Functions	58
Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy	57
Host Interactions with Engineered T-cell Micropharmacies	55
T-cell Senescence in the Tumor Microenvironment	55
Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies	54
CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity	53
Profiling Multiple CD8+ T-cell Functional Dimensions Enhances Breast Cancer Immune Assessment	51
Abstract P009: Correlation between immune modulation of macrophage recruitment and new blood vessel formation in a subcutaneous murine mouse model of colorectal cancer	51
Abstract P073: Gut microbiota shift in melanoma patients undergoing immunotherapy is associated with clinical response	51
Abstract IA17: The power of ONE: Immunology in the age of single cell genomics	50
A Sampling of Highlights from the Literature	49
High Mobility Group Protein B1 Decreases Surface Localization of PD-1 to Augment T-cell Activation	49

Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity	49
Sensory Nerves Impede the Formation of Tertiary Lymphoid Structures and Development of Protective Antimelanoma Immune Responses	48
Low TCR Binding Strength Results in Increased Progenitor-like CD8+ Tumor-Infiltrating Lymphocytes	47
Harnessing Microbiota to Improve Immunotherapy for Gastrointestinal Cancers	47
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects	47
Engineering CD20 CARs with a Twist	47
Ncoa2 Promotes CD8+ T cell–Mediated Antitumor Immunity by Stimulating T-cell Activation via Upregulation of PGC-1α Critical for Mitochondrial Function	47
A Sampling of Highlights from the Literature	47
IL11: A Specific Repressor of Tumor-Specific CD4+ T Cells	44
Loss of LRRC33-Dependent TGFβ1 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy	44
Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation	43
KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer	42
The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment	41
Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer	41
Ethnicity, Immunity, and Outcomes: Biology versus Socioeconomic Status	39